Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 37.43% | 42.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 37.43% | 42.18% | |||
| Cost of Revenue | -25.29% | 57.05% | |||
| Gross Profit | 129.28% | 24.89% | |||
| SG&A Expenses | -4.66% | 12.89% | |||
| Depreciation & Amortization | -10.42% | -1.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.14% | 48.91% | |||
| Operating Income | 271.39% | 21.07% | |||
| Income Before Tax | 299.48% | 18.89% | |||
| Income Tax Expenses | 160.69% | 42.31% | |||
| Earnings from Continuing Operations | 376.06% | 8.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 376.06% | 8.99% | |||
| EBIT | 271.39% | 21.07% | |||
| EBITDA | 254.79% | 19.78% | |||
| EPS Basic | 284.00% | 50.00% | |||
| Normalized Basic EPS | 207.02% | 62.50% | |||
| EPS Diluted | 284.00% | 50.00% | |||
| Normalized Diluted EPS | 207.02% | 62.50% | |||
| Average Basic Shares Outstanding | 23.96% | -27.35% | |||
| Average Diluted Shares Outstanding | 23.96% | -27.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||